Background:Calcium sandoz-250 is an Ayurvedic calcium supplement, containing Khatika Churna. Bioavailability study of the formulation is essential for estimation of peak plasma concentration (Cmax), time to Cmax and rate of absorption.Aim:To evaluate the absorption parameters of calcium sandoz-250 in albino rats by atomic absorption spectroscopic (AAS) method.Materials and Methods:Study was carried out as a single dose, open-label, randomized study. Estimation of calcium was carried out by AAS, after validating the method for a few parameters for the estimation. Pharmacokinetic parameters such as Cmax, time to peak concentration (Tmax), area under the plasma concentration - time curve were calculated for calcium on administration of calcium sandoz-250.Results:Linearity curve was plotted for 0.5-2.5 ppm, given R2 value 0.9975. The Cmax, i.e. Cmax after administration of calcium sandoz-250 was 0.793 mg/ml at 90 min (Tmax). Measurable calcium-blood levels were noticed in all subjects up to 3.0 h after administration of calcium sandoz-250.Conclusion:Calcium sandoz-250, consisting of Khatika Churna, increases the blood calcium level in albino rats.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.